1 Introduction to Research & Analysis Reports
1.1 Melbine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Melbine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Melbine Overall Market Size
2.1 Global Melbine Market Size: 2022 VS 2029
2.2 Global Melbine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Melbine Sales: 2018-2029
3 Company Landscape
3.1 Top Melbine Players in Global Market
3.2 Top Global Melbine Companies Ranked by Revenue
3.3 Global Melbine Revenue by Companies
3.4 Global Melbine Sales by Companies
3.5 Global Melbine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Melbine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Melbine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Melbine Players in Global Market
3.8.1 List of Global Tier 1 Melbine Companies
3.8.2 List of Global Tier 2 and Tier 3 Melbine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Melbine Market Size Markets, 2022 & 2029
4.1.2 Sustained Release Tablet
4.1.3 Enteric Coatel Tablets
4.2 By Type – Global Melbine Revenue & Forecasts
4.2.1 By Type – Global Melbine Revenue, 2018-2023
4.2.2 By Type – Global Melbine Revenue, 2024-2029
4.2.3 By Type – Global Melbine Revenue Market Share, 2018-2029
4.3 By Type – Global Melbine Sales & Forecasts
4.3.1 By Type – Global Melbine Sales, 2018-2023
4.3.2 By Type – Global Melbine Sales, 2024-2029
4.3.3 By Type – Global Melbine Sales Market Share, 2018-2029
4.4 By Type – Global Melbine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Melbine Market Size, 2022 & 2029
5.1.2 Medicine
5.1.3 Chemistry
5.2 By Application – Global Melbine Revenue & Forecasts
5.2.1 By Application – Global Melbine Revenue, 2018-2023
5.2.2 By Application – Global Melbine Revenue, 2024-2029
5.2.3 By Application – Global Melbine Revenue Market Share, 2018-2029
5.3 By Application – Global Melbine Sales & Forecasts
5.3.1 By Application – Global Melbine Sales, 2018-2023
5.3.2 By Application – Global Melbine Sales, 2024-2029
5.3.3 By Application – Global Melbine Sales Market Share, 2018-2029
5.4 By Application – Global Melbine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Melbine Market Size, 2022 & 2029
6.2 By Region – Global Melbine Revenue & Forecasts
6.2.1 By Region – Global Melbine Revenue, 2018-2023
6.2.2 By Region – Global Melbine Revenue, 2024-2029
6.2.3 By Region – Global Melbine Revenue Market Share, 2018-2029
6.3 By Region – Global Melbine Sales & Forecasts
6.3.1 By Region – Global Melbine Sales, 2018-2023
6.3.2 By Region – Global Melbine Sales, 2024-2029
6.3.3 By Region – Global Melbine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Melbine Revenue, 2018-2029
6.4.2 By Country – North America Melbine Sales, 2018-2029
6.4.3 US Melbine Market Size, 2018-2029
6.4.4 Canada Melbine Market Size, 2018-2029
6.4.5 Mexico Melbine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Melbine Revenue, 2018-2029
6.5.2 By Country – Europe Melbine Sales, 2018-2029
6.5.3 Germany Melbine Market Size, 2018-2029
6.5.4 France Melbine Market Size, 2018-2029
6.5.5 U.K. Melbine Market Size, 2018-2029
6.5.6 Italy Melbine Market Size, 2018-2029
6.5.7 Russia Melbine Market Size, 2018-2029
6.5.8 Nordic Countries Melbine Market Size, 2018-2029
6.5.9 Benelux Melbine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Melbine Revenue, 2018-2029
6.6.2 By Region – Asia Melbine Sales, 2018-2029
6.6.3 China Melbine Market Size, 2018-2029
6.6.4 Japan Melbine Market Size, 2018-2029
6.6.5 South Korea Melbine Market Size, 2018-2029
6.6.6 Southeast Asia Melbine Market Size, 2018-2029
6.6.7 India Melbine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Melbine Revenue, 2018-2029
6.7.2 By Country – South America Melbine Sales, 2018-2029
6.7.3 Brazil Melbine Market Size, 2018-2029
6.7.4 Argentina Melbine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Melbine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Melbine Sales, 2018-2029
6.8.3 Turkey Melbine Market Size, 2018-2029
6.8.4 Israel Melbine Market Size, 2018-2029
6.8.5 Saudi Arabia Melbine Market Size, 2018-2029
6.8.6 UAE Melbine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Xi’an ruixi Biological Technological Co.L
7.1.1 Xi’an ruixi Biological Technological Co.L Company Summary
7.1.2 Xi’an ruixi Biological Technological Co.L Business Overview
7.1.3 Xi’an ruixi Biological Technological Co.L Melbine Major Product Offerings
7.1.4 Xi’an ruixi Biological Technological Co.L Melbine Sales and Revenue in Global (2018-2023)
7.1.5 Xi’an ruixi Biological Technological Co.L Key News & Latest Developments
7.2 Sino-american Shanghai Squibb Pharmaceutical Co. LTD
7.2.1 Sino-american Shanghai Squibb Pharmaceutical Co. LTD Company Summary
7.2.2 Sino-american Shanghai Squibb Pharmaceutical Co. LTD Business Overview
7.2.3 Sino-american Shanghai Squibb Pharmaceutical Co. LTD Melbine Major Product Offerings
7.2.4 Sino-american Shanghai Squibb Pharmaceutical Co. LTD Melbine Sales and Revenue in Global (2018-2023)
7.2.5 Sino-american Shanghai Squibb Pharmaceutical Co. LTD Key News & Latest Developments
7.3 Shenzhen Zhonglian Pharmaceutical Co., Ltd.
7.3.1 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Company Summary
7.3.2 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Business Overview
7.3.3 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Melbine Major Product Offerings
7.3.4 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Melbine Sales and Revenue in Global (2018-2023)
7.3.5 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Key News & Latest Developments
7.4 Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd
7.4.1 Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd Company Summary
7.4.2 Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd Business Overview
7.4.3 Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd Melbine Major Product Offerings
7.4.4 Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd Melbine Sales and Revenue in Global (2018-2023)
7.4.5 Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd Key News & Latest Developments
7.5 Shijiazhuang Xinhua Pharmaceutical Co., Ltd.
7.5.1 Shijiazhuang Xinhua Pharmaceutical Co., Ltd. Company Summary
7.5.2 Shijiazhuang Xinhua Pharmaceutical Co., Ltd. Business Overview
7.5.3 Shijiazhuang Xinhua Pharmaceutical Co., Ltd. Melbine Major Product Offerings
7.5.4 Shijiazhuang Xinhua Pharmaceutical Co., Ltd. Melbine Sales and Revenue in Global (2018-2023)
7.5.5 Shijiazhuang Xinhua Pharmaceutical Co., Ltd. Key News & Latest Developments
7.6 Beijing Liling Hengtai Drug Co., Ltd.
7.6.1 Beijing Liling Hengtai Drug Co., Ltd. Company Summary
7.6.2 Beijing Liling Hengtai Drug Co., Ltd. Business Overview
7.6.3 Beijing Liling Hengtai Drug Co., Ltd. Melbine Major Product Offerings
7.6.4 Beijing Liling Hengtai Drug Co., Ltd. Melbine Sales and Revenue in Global (2018-2023)
7.6.5 Beijing Liling Hengtai Drug Co., Ltd. Key News & Latest Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Melbine Major Product Offerings
7.7.4 AstraZeneca Melbine Sales and Revenue in Global (2018-2023)
7.7.5 AstraZeneca Key News & Latest Developments
7.8 MIMS
7.8.1 MIMS Company Summary
7.8.2 MIMS Business Overview
7.8.3 MIMS Melbine Major Product Offerings
7.8.4 MIMS Melbine Sales and Revenue in Global (2018-2023)
7.8.5 MIMS Key News & Latest Developments
7.9 Chengdu Hengrui Pharmaceutical
7.9.1 Chengdu Hengrui Pharmaceutical Company Summary
7.9.2 Chengdu Hengrui Pharmaceutical Business Overview
7.9.3 Chengdu Hengrui Pharmaceutical Melbine Major Product Offerings
7.9.4 Chengdu Hengrui Pharmaceutical Melbine Sales and Revenue in Global (2018-2023)
7.9.5 Chengdu Hengrui Pharmaceutical Key News & Latest Developments
7.10 Merck Healthcare KGaA
7.10.1 Merck Healthcare KGaA Company Summary
7.10.2 Merck Healthcare KGaA Business Overview
7.10.3 Merck Healthcare KGaA Melbine Major Product Offerings
7.10.4 Merck Healthcare KGaA Melbine Sales and Revenue in Global (2018-2023)
7.10.5 Merck Healthcare KGaA Key News & Latest Developments
7.11 Shandong Sibang Pharmaceutical Co. LTD
7.11.1 Shandong Sibang Pharmaceutical Co. LTD Company Summary
7.11.2 Shandong Sibang Pharmaceutical Co. LTD Melbine Business Overview
7.11.3 Shandong Sibang Pharmaceutical Co. LTD Melbine Major Product Offerings
7.11.4 Shandong Sibang Pharmaceutical Co. LTD Melbine Sales and Revenue in Global (2018-2023)
7.11.5 Shandong Sibang Pharmaceutical Co. LTD Key News & Latest Developments
7.12 Hebei Samshi Pharmaceutical Co. LTD
7.12.1 Hebei Samshi Pharmaceutical Co. LTD Company Summary
7.12.2 Hebei Samshi Pharmaceutical Co. LTD Melbine Business Overview
7.12.3 Hebei Samshi Pharmaceutical Co. LTD Melbine Major Product Offerings
7.12.4 Hebei Samshi Pharmaceutical Co. LTD Melbine Sales and Revenue in Global (2018-2023)
7.12.5 Hebei Samshi Pharmaceutical Co. LTD Key News & Latest Developments
7.13 Yuekang Pharmaceutical Group Co. LTD
7.13.1 Yuekang Pharmaceutical Group Co. LTD Company Summary
7.13.2 Yuekang Pharmaceutical Group Co. LTD Melbine Business Overview
7.13.3 Yuekang Pharmaceutical Group Co. LTD Melbine Major Product Offerings
7.13.4 Yuekang Pharmaceutical Group Co. LTD Melbine Sales and Revenue in Global (2018-2023)
7.13.5 Yuekang Pharmaceutical Group Co. LTD Key News & Latest Developments
7.14 Qingdao Huanghai Pharmaceutical Co. LTD
7.14.1 Qingdao Huanghai Pharmaceutical Co. LTD Company Summary
7.14.2 Qingdao Huanghai Pharmaceutical Co. LTD Business Overview
7.14.3 Qingdao Huanghai Pharmaceutical Co. LTD Melbine Major Product Offerings
7.14.4 Qingdao Huanghai Pharmaceutical Co. LTD Melbine Sales and Revenue in Global (2018-2023)
7.14.5 Qingdao Huanghai Pharmaceutical Co. LTD Key News & Latest Developments
7.15 Guizhou Tian ‘an Pharmaceutical Co. LTD
7.15.1 Guizhou Tian ‘an Pharmaceutical Co. LTD Company Summary
7.15.2 Guizhou Tian ‘an Pharmaceutical Co. LTD Business Overview
7.15.3 Guizhou Tian ‘an Pharmaceutical Co. LTD Melbine Major Product Offerings
7.15.4 Guizhou Tian ‘an Pharmaceutical Co. LTD Melbine Sales and Revenue in Global (2018-2023)
7.15.5 Guizhou Tian ‘an Pharmaceutical Co. LTD Key News & Latest Developments
8 Global Melbine Production Capacity, Analysis
8.1 Global Melbine Production Capacity, 2018-2029
8.2 Melbine Production Capacity of Key Manufacturers in Global Market
8.3 Global Melbine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Melbine Supply Chain Analysis
10.1 Melbine Industry Value Chain
10.2 Melbine Upstream Market
10.3 Melbine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Melbine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界のメルビン市場予測2023-2029：徐放性錠剤、腸溶コアテル錠 |
| 【英語タイトル】Melbine Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5753 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：116 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界のメルビン市場規模と予測を収録しています。・世界のメルビン市場：売上、2018年-2023年、2024年-2029年 ・世界のメルビン市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のメルビン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「徐放性錠剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 メルビンのグローバル主要企業は、Xi'an ruixi Biological Technological Co.L、 Sino-american Shanghai Squibb Pharmaceutical Co. LTD、 Shenzhen Zhonglian Pharmaceutical Co., Ltd.、 Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd、 Shijiazhuang Xinhua Pharmaceutical Co., Ltd.、 Beijing Liling Hengtai Drug Co., Ltd.、 AstraZeneca、 MIMS、 Chengdu Hengrui Pharmaceutical、 Merck Healthcare KGaA、 Shandong Sibang Pharmaceutical Co. LTD、 Hebei Samshi Pharmaceutical Co. LTD、 Yuekang Pharmaceutical Group Co. LTD、 Qingdao Huanghai Pharmaceutical Co. LTD、 Guizhou Tian 'an Pharmaceutical Co. LTDなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、メルビンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のメルビン市場：タイプ別、2018年-2023年、2024年-2029年 世界のメルビン市場：タイプ別市場シェア、2022年 ・徐放性錠剤、腸溶コアテル錠 世界のメルビン市場：用途別、2018年-2023年、2024年-2029年 世界のメルビン市場：用途別市場シェア、2022年 ・医学、化学 世界のメルビン市場：地域・国別、2018年-2023年、2024年-2029年 世界のメルビン市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるメルビンのグローバル売上、2018年-2023年 ・主要企業におけるメルビンのグローバル売上シェア、2022年 ・主要企業におけるメルビンのグローバル販売量、2018年-2023年 ・主要企業におけるメルビンのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Xi'an ruixi Biological Technological Co.L、 Sino-american Shanghai Squibb Pharmaceutical Co. LTD、 Shenzhen Zhonglian Pharmaceutical Co., Ltd.、 Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd、 Shijiazhuang Xinhua Pharmaceutical Co., Ltd.、 Beijing Liling Hengtai Drug Co., Ltd.、 AstraZeneca、 MIMS、 Chengdu Hengrui Pharmaceutical、 Merck Healthcare KGaA、 Shandong Sibang Pharmaceutical Co. LTD、 Hebei Samshi Pharmaceutical Co. LTD、 Yuekang Pharmaceutical Group Co. LTD、 Qingdao Huanghai Pharmaceutical Co. LTD、 Guizhou Tian 'an Pharmaceutical Co. LTD ************************************************************* ・調査・分析レポートの概要 メルビン市場の定義 市場セグメント 世界のメルビン市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のメルビン市場規模 世界のメルビン市場規模：2022年 VS 2029年 世界のメルビン市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのメルビンの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のメルビン製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：徐放性錠剤、腸溶コアテル錠 メルビンのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：医学、化学 メルビンの用途別グローバル売上・予測 ・地域別市場分析 地域別メルビン市場規模 2022年と2029年 地域別メルビン売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Xi'an ruixi Biological Technological Co.L、 Sino-american Shanghai Squibb Pharmaceutical Co. LTD、 Shenzhen Zhonglian Pharmaceutical Co., Ltd.、 Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd、 Shijiazhuang Xinhua Pharmaceutical Co., Ltd.、 Beijing Liling Hengtai Drug Co., Ltd.、 AstraZeneca、 MIMS、 Chengdu Hengrui Pharmaceutical、 Merck Healthcare KGaA、 Shandong Sibang Pharmaceutical Co. LTD、 Hebei Samshi Pharmaceutical Co. LTD、 Yuekang Pharmaceutical Group Co. LTD、 Qingdao Huanghai Pharmaceutical Co. LTD、 Guizhou Tian 'an Pharmaceutical Co. LTD ... |
This report aims to provide a comprehensive presentation of the global market for Melbine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Melbine. This report contains market size and forecasts of Melbine in global, including the following market information:
Global Melbine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Melbine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Melbine companies in 2022 (%)
The global Melbine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Sustained Release Tablet Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Melbine include Xi’an ruixi Biological Technological Co.L, Sino-american Shanghai Squibb Pharmaceutical Co. LTD, Shenzhen Zhonglian Pharmaceutical Co., Ltd., Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd, Shijiazhuang Xinhua Pharmaceutical Co., Ltd., Beijing Liling Hengtai Drug Co., Ltd., AstraZeneca, MIMS and Chengdu Hengrui Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Melbine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Melbine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Melbine Market Segment Percentages, by Type, 2022 (%)
Sustained Release Tablet
Enteric Coatel Tablets
Global Melbine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Melbine Market Segment Percentages, by Application, 2022 (%)
Medicine
Chemistry
Global Melbine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Melbine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Melbine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Melbine revenues share in global market, 2022 (%)
Key companies Melbine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Melbine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Xi’an ruixi Biological Technological Co.L
Sino-american Shanghai Squibb Pharmaceutical Co. LTD
Shenzhen Zhonglian Pharmaceutical Co., Ltd.
Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd
Shijiazhuang Xinhua Pharmaceutical Co., Ltd.
Beijing Liling Hengtai Drug Co., Ltd.
AstraZeneca
MIMS
Chengdu Hengrui Pharmaceutical
Merck Healthcare KGaA
Shandong Sibang Pharmaceutical Co. LTD
Hebei Samshi Pharmaceutical Co. LTD
Yuekang Pharmaceutical Group Co. LTD
Qingdao Huanghai Pharmaceutical Co. LTD
Guizhou Tian ‘an Pharmaceutical Co. LTD
Outline of Major Chapters:
Chapter 1: Introduces the definition of Melbine, market overview.
Chapter 2: Global Melbine market size in revenue and volume.
Chapter 3: Detailed analysis of Melbine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Melbine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Melbine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界のメルビン市場予測2023-2029：徐放性錠剤、腸溶コアテル錠] (コード：MMG23JU5753)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界のメルビン市場予測2023-2029：徐放性錠剤、腸溶コアテル錠]についてメールでお問い合わせ |
